|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Rituxan (Rituximab). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (550)
Cases resulting in a serious event (545)
Cases resulting in death (113)
Cases resulting in life threatening events (66)
Cases resulting in hospitalization (233)
Cases resulting in disability (26)
Cases resulting in other serious reactions (238)
Below is a sample of reports where side effects / adverse reactions may be related to Rituxan (Rituximab). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 54 year old male receiving Rituxan (Rituximab)
Reported by a physician from Japan on 2007-10-31
Patient: 54 year old male
Adverse reactions / side effects: Hepatic Failure, Hepatitis B
Adverse event resulted in: death
Suspect drug(s):
Rituxan (Rituximab)
Other drugs received by patient: Cyclophosphamide; Doxorubicin HCL; Vincristine; Dexamethasone 0.5mg TAB; Etoposide; Ifosfamide; Methotrexate
Adverse event in 58 year old female receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 58 year old female
Adverse reactions / side effects: Productive Cough, Vomiting, Arthralgia, Oedema Peripheral
Adverse event resulted in: hospitalization
Suspect drug(s):
Rituxan (Rituximab)
Adverse event in female receiving Rituxan (Rituximab)
Reported by a physician from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Bladder Cancer
Suspect drug(s):
Rituxan (Rituximab)
Adverse event in male receiving Rituxan (Rituximab)
Reported by a physician from Norway on 2007-10-30
Patient: male
Adverse reactions / side effects: Squamous Cell Carcinoma
Adverse event resulted in: hospitalization
Suspect drug(s):
Enbrel
Enbrel
Indication: Psoriatic Arthropathy
Humira
Indication: Psoriatic Arthropathy
Remicade
Indication: Psoriatic Arthropathy
Rituxan
Indication: Psoriatic Arthropathy
Other drugs received by patient: Prednisolon; Methotrexate; Rituximab
Adverse event in male receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: male
Adverse reactions / side effects: Blindness
Suspect drug(s):
Cytoxan
Dosage: completed 5 cycles
Start date: 2006-01-01
End date: 2006-12-01
Fludara
Dosage: completed 5 cycles
Start date: 2006-01-01
End date: 2006-12-01
Rituxan
Dosage: completed 5 cycles
Start date: 2006-01-01
End date: 2006-12-01
Adverse event in 60 year old female receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 60 year old female
Adverse reactions / side effects: Lymphoma Transformation
Suspect drug(s):
Rituxan (Rituximab)
Adverse event in 66 year old female receiving Rituxan (Rituximab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: 66 year old female
Adverse reactions / side effects: Pneumonia, Renal Failure, Neutropenia
Suspect drug(s):
Cyclophosphamide
Dosage: 600 mg/m2, q3w
Indication: Lymphoma
Pentostatin
Dosage: 4 mg/m2, q3w
Indication: Lymphoma
Rituxan
Dosage: 100 mg, q3w
Indication: Lymphoma
Rituxan
Dosage: 375 mg/m2, q3w
Other drugs received by patient: IV Hydration (Unk Ingredients); 5-Hydroxytryptamine; Acetaminophen; Diphenhydramine HCL; Allopurinol; Trimethoprim + Sulfamethoxazole; Medication (Unk Ingredient); Neupogen
Adverse event in 73 year old female receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 73 year old female
Adverse reactions / side effects: Renal Failure, Cardiac Failure, Sepsis, Cerebrovascular Disorder
Adverse event resulted in: death
Suspect drug(s):
Cyclophosphamide
Dosage: 600 mg/m2, q3w
Indication: Chronic Lymphocytic Leukaemia
Pentostatin
Dosage: 4 mg/m2, q3w
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: 100 mg, q3w
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: 375 mg/m2, q3w
Other drugs received by patient: 5-Hydroxytryptamine; Hydration NOS; Acetaminophen; Diphenhydramine HCL; Allopurinol; Trimethoprim + Sulfamethoxazole; Medication (Unk Ingredient); Neupogen
Adverse event in 66 year old female receiving Rituxan (Rituximab)
Reported by a physician from Portugal on 2007-10-29
Patient: 66 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Bone Marrow Failure, Pancytopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Methotrexate
Dosage: 15 mg, 1/week
Indication: Rheumatoid Arthritis
Rituxan
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Folic Acid; Methylprednisolone; Furosemide; Warfarin Sodium
Adverse event in receiving Rituxan (Rituximab)
Reported by a physician from Italy on 2007-10-29
Patient:
Adverse reactions / side effects: JC Virus Infection, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death
Suspect drug(s):
Cyclophosphamide
Dosage: 7 g/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Dosage: 2 g/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 75 mg/m2, x2
Rituxan
Dosage: 375 mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Adverse event in receiving Rituxan (Rituximab)
Reported by a physician from Greece on 2007-10-29
Patient:
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: death
Suspect drug(s):
Rituxan (Rituximab)
Other drugs received by patient: Dexamethasone 0.5mg TAB; Cyclophosphamide
Adverse event in 65 year old male receiving Rituxan (Rituximab)
Reported by a physician from United States on 2007-10-29
Patient: 65 year old male
Adverse reactions / side effects: Renal Failure, Transient Ischaemic Attack, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Pentostatin
Dosage: 4 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: 100 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Other drugs received by patient: Fluids (Unk Ingredients); IV Hydration (Unk Ingredients); Anti Nausea Medicine Unkown Name; Anti Nausea Medicine Unkown Name; Acetaminophen; Diphenhydramine HCL; Allopurinol; Trimethoprim + Sulfamethoxazole; Neupogen
Adverse event in 65 year old female receiving Rituxan (Rituximab)
Reported by a physician from United States on 2007-10-29
Patient: 65 year old female
Adverse reactions / side effects: Cardiac Failure, Myocardial Infarction
Suspect drug(s):
Cyclophosphamide
Dosage: 600 mg/m2, q3w
Indication: Chronic Lymphocytic Leukaemia
Pentostatin
Dosage: 4 mg/m2, q3w
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: 100 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: 375 mg/m2, x2
Adverse event in 72 year old female receiving Rituxan (Rituximab)
Reported by a physician from United States on 2007-10-29
Patient: 72 year old female
Adverse reactions / side effects: Neutropenic Sepsis, Haemolytic Anaemia
Suspect drug(s):
Cyclophosphamide
Dosage: 600 mg/m2, q3w
Indication: Chronic Lymphocytic Leukaemia
Pentostatin
Dosage: 4 mg/m2, q3w
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: 100 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: 375 mg/m2, unk
Other drugs received by patient: Hydration (Unk Ingredients)
Adverse event in 23 year old female receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 23 year old female
Adverse reactions / side effects: Oedema Peripheral, Lymphoedema
Suspect drug(s):
Rituxan (Rituximab)
Other drugs received by patient: Celebrex; Prozac; Solu-Medrol
Adverse event in 66 year old female receiving Rituxan (Rituximab)
Reported by a physician from Portugal on 2007-10-26
Patient: 66 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Liver Function Test Abnormal, Hypovolaemia
Suspect drug(s):
Methotrexate
Dosage: 15 mg, 1/week
Administration route: Oral
Indication: Rheumatoid Arthritis
Rituxan
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Folic Acid; Medrol; Furosemide
Adverse event in 62 year old female receiving Rituxan (Rituximab)
Reported by a physician from United Kingdom on 2007-10-26
Patient: 62 year old female
Adverse reactions / side effects: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Cyclophosphamide
Dosage: unk, unk
Indication: Chronic Lymphocytic Leukaemia Transformation
Start date: 2003-09-01
End date: 2004-02-01
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: unk, unk
Indication: Chronic Lymphocytic Leukaemia Transformation
Start date: 2003-09-01
End date: 2004-02-01
Doxorubicin HCL
Indication: Chronic Lymphocytic Leukaemia
Prednisone
Indication: Chronic Lymphocytic Leukaemia Transformation
Start date: 2003-09-01
End date: 2004-02-01
Prednisone
Indication: Chronic Lymphocytic Leukaemia
Rituxan
Dosage: unk, unk
Indication: Chronic Lymphocytic Leukaemia Transformation
Start date: 2003-09-01
End date: 2006-02-01
Rituxan
Indication: Chronic Lymphocytic Leukaemia
Vincristine
Indication: Chronic Lymphocytic Leukaemia Transformation
Start date: 2003-09-01
End date: 2004-02-01
Vincristine
Indication: Chronic Lymphocytic Leukaemia
Other drugs received by patient: Chlorambucil; Fludarabine Phosphate
Adverse event in 29 year old receiving Rituxan (Rituximab)
Reported by a physician from United Kingdom on 2007-10-26
Patient: 29 year old
Adverse reactions / side effects: Grand MAL Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 750 mg, unk
Indication: Systemic Lupus Erythematosus
Start date: 2006-11-25
Rituxan
Dosage: 1 g, unk
Indication: Systemic Lupus Erythematosus
Start date: 2006-11-24
Other drugs received by patient: Methylprednisolone; Plaquenil; Atorvastatin; Lansoprazole; Atenolol; Irbesartan
Adverse event in female receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Tachycardia, Cognitive Disorder, Cerebrovascular Accident
Suspect drug(s):
Rituxan
Dosage: unk unk, 1/week
Indication: Waldenstrom's Macroglobulinaemia
Start date: 2006-02-01
Rituxan
Dosage: unk, unknown
Start date: 2006-04-01
Other drugs received by patient: Chemotherapy (Unk Ingredients)
Adverse event in male receiving Rituxan (Rituximab)
Reported by a physician from Australia on 2007-10-26
Patient: male
Adverse reactions / side effects: Deep Vein Thrombosis
Suspect drug(s):
Rituxan (Rituximab)
Other drugs received by patient: Levothyroxine Sodium; Felodipine; Allopurinol; Methotrexate; Atacand; Lercanidipine; Amaryl; Zocor; Tamsulosin HCL; Frusemide; Renitec; Alphapress; Prednisone; Labetalol HCL; Epogen; Span-K; Warfarin Sodium; Sodibic
Adverse event in 30 year old female receiving Rituxan (Rituximab)
Reported by a pharmacist from United Kingdom on 2007-10-26
Patient: 30 year old female
Adverse reactions / side effects: Vomiting, Nausea, Headache, Convulsion
Suspect drug(s):
Rituxan (Rituximab)
Adverse event in 81 year old receiving Rituxan (Rituximab)
Reported by a physician from Japan on 2007-10-26
Patient: 81 year old
Adverse reactions / side effects: Intestinal Perforation, Hepatic Failure
Adverse event resulted in: life threatening event
Suspect drug(s):
Rituxan (Rituximab)
Adverse event in female receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Gastrointestinal Ulcer, Irritable Bowel Syndrome
Suspect drug(s):
Rituxan
Dosage: unk, 1/week
Indication: Waldenstrom's Macroglobulinaemia
Start date: 2006-02-01
Rituxan
Start date: 2005-11-01
Other drugs received by patient: Chemotherapy (Unk Ingredients)
Adverse event in male receiving Rituxan (Rituximab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: male, weighing 79.4 kg (174.6 pounds)
Adverse reactions / side effects: Regurgitation, Oedema Peripheral, Pain, Headache
Suspect drug(s):
Rituxan (Rituximab)
Other drugs received by patient: Warfarin Sodium; Metformin; Methotrexate; Misoprostol; Folic Acid
Adverse event in male receiving Rituxan (Rituximab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: male
Adverse reactions / side effects: Wegener's Granulomatosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Rituxan (Rituximab)
Other drugs received by patient: Prednisone; Prilosec; Levothyroxine Sodium; Calcium; Vitamin D; Renal Caps; Lipitor; Bactrim; Actonel; Tylenol (Caplet); PRE-Medications (Unk Ingredients); Solu-Medrol; Benadryl; Benadryl
|
